Atle Fund Management AB Diversified Active

Location: Stockholm, Sweden

CIK: 0001381843 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value: $164M (100.0% shares, 0.0% debt)

Holdings (38)

LLY ELI LILLY & CO 15.0%
Value $24.58M Shares 27,144 Est. Cost $646.23 Unrealized +22.4%
UNH UFP TECHNOLOGIES INC 9.8%
Value $16.13M Shares 31,680 Est. Cost $497.50 Unrealized -4.9%
MRK MERCK & CO INC 8.5%
Value $13.96M Shares 112,734 Est. Cost $106.43 Unrealized +14.4%
TMO THERMO FISHER SCIENTIFIC INC 6.6%
Value $10.76M Shares 19,458 Est. Cost $515.71 Unrealized +10.5%
AMGN AMGEN INC 5.3%
Value $8.62M Shares 27,589 Est. Cost $264.91 Unrealized +5.4%
BSX BOSTON SCIENTIFIC CORP 5.0%
Value $8.206M Shares 106,557 Est. Cost $59.99 Unrealized +22.0%
REGN REGENERON PHARMACEUTICALS 4.4%
Value $7.245M Shares 6,893 Est. Cost $875.37 Unrealized +10.1%
VRTX VERTEX PHARMACEUTICALS INC 4.3%
Value $7.075M Shares 15,095 Est. Cost $392.41 Unrealized +10.6%
COR CENCORA INC 4.2%
Value $6.831M Shares 30,320 Est. Cost $203.56 Unrealized +12.3%
SYK STRYKER CORPORATION 4.1%
Value $6.799M Shares 19,983 Est. Cost $294.96 Unrealized +13.0%
ABBV ABBVIE INC 3.7%
Value $6.109M Shares 35,618 Est. Cost $145.54 Unrealized +8.0%
DXCM DEXCOM INC 2.4%
Value $3.91M Shares 34,483 Est. Cost $113.61 Unrealized +11.3%
EW EDWARDS LIFESCIENCES CORP 2.1%
Value $3.372M Shares 36,505 Est. Cost $77.31 Unrealized +14.5%
NBIX NEUROCRINE BIOSCIENCES INC 2.0%
Value $3.253M Shares 23,630 Est. Cost $130.35 Unrealized +5.2%
IQV IQVIA HLDGS INC 1.8%
Value $2.957M Shares 13,984 Est. Cost $211.42 Unrealized +7.5%
MOH MOLINA HEALTHCARE INC 1.7%
Value $2.824M Shares 9,500 Est. Cost $352.69 Unrealized -3.7%
CAH CARDINAL HEALTH INC 1.6%
Value $2.704M Shares 27,500 Est. Cost $62.95 Unrealized +57.6%
UFPT UFP TECHNOLOGIES INC 1.6%
Value $2.586M Shares 9,800 Est. Cost $247.04 Unrealized 0.0%
MIRM MIRUM PHARMACEUTICALS INC 1.6%
Value $2.571M Shares 75,200 Est. Cost $27.49 Unrealized -4.6%
INTRA-CELLULAR THERAPIES INC 1.5%
Value $2.455M Shares 35,841 Est. Cost $69.84 Unrealized
IONS IONIS PHARMACEUTICALS INC 1.2%
Value $1.939M Shares 40,691 Est. Cost $47.75 Unrealized -14.1%
MERUS N V 1.1%
Value $1.825M Shares 30,837 Est. Cost $34.08 Unrealized
CRBP CORBUS PHARMACEUTICALS HLDGS 1.1%
Value $1.769M Shares 39,100 Est. Cost $25.15 Unrealized +67.3%
ALKS ALKERMES PLC 1.0%
Value $1.658M Shares 68,800 Est. Cost $24.53 Unrealized 0.0%
OPCH OPTION CARE HEALTH INC 0.9%
Value $1.507M Shares 54,395 Est. Cost $31.91 Unrealized -6.6%
FOLD AMICUS THERAPEUTICS INC 0.9%
Value $1.47M Shares 148,207 Est. Cost $12.51 Unrealized -18.0%
NAMS NEWAMSTERDAM PHARMA COMPANY 0.9%
Value $1.456M Shares 75,794 Est. Cost $20.13 Unrealized -0.3%
KRYS KRYSTAL BIOTECH INC 0.9%
Value $1.4M Shares 7,624 Est. Cost $117.70 Unrealized +42.6%
BBIO BRIDGEBIO PHARMA INC 0.8%
Value $1.353M Shares 53,432 Est. Cost $29.94 Unrealized -8.7%
ACLX ARCELLX INC 0.8%
Value $1.242M Shares 22,496 Est. Cost $51.99 Unrealized +4.6%
HRMY HARMONY BIOSCIENCES HLDGS IN 0.6%
Value $1.053M Shares 34,900 Est. Cost $28.53 Unrealized +5.4%
IMCR IMMUNOCORE HLDGS PLC 0.5%
Value $806K Shares 23,778 Est. Cost $65.64 Unrealized
AUTL AUTOLUS THERAPEUTICS PLC 0.5%
Value $787K Shares 226,145 Est. Cost $4.74 Unrealized
MORPHIC HLDG INC 0.4%
Value $688K Shares 20,199 Est. Cost $30.23 Unrealized
PHVS PHARVARIS N V 0.4%
Value $645K Shares 34,328 Est. Cost $20.35 Unrealized 0.0%
MGNX MACROGENICS INC 0.4%
Value $609K Shares 143,407 Est. Cost $11.59 Unrealized -16.0%
CABA CABALETTA BIO INC 0.3%
Value $481K Shares 64,321 Est. Cost $20.20 Unrealized -39.3%
MERSANA THERAPEUTICS INC 0.2%
Value $372K Shares 184,900 Est. Cost $3.35 Unrealized